Inhibikase Therapeutics
IKT
IKT
47 hedge funds and large institutions have $106M invested in Inhibikase Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 23 closing their positions.
Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
0.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
11
Reduced
5
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$5.32M |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$2.08M |
3 |
3
Blackstone Inc
New York
|
$5.14M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$6.29M |
5 |
5
State Street
Boston,
Massachusetts
|
$776K |